You just read:

JHL Biotech Submits Clinical Trial Application in Europe for Proposed Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers

News provided by

JHL Biotech

Dec 20, 2017, 09:17 EST